Harbour BioMed | Partnership - Advancing Innovative Drugs through Global Strategic Partnerships and Ecosystem

Why Partner With Us

Partnerships are integral to Harbour BioMed's strategic vision of building a fully integrated biopharmaceutical company. We operate global R&D centers in the USA, Europe, and China to identify and leverage local innovation for global development.

Our growing innovative portfolio reflects successful collaborations with industry and academic institutions worldwide, concentrated in the fields of immunology, immuno-oncology and more.

Innovative Platforms

Harbour BioMed has built a globally leading integrated antibody discovery platform. Three core technologies work in deep synergy to accelerate the translation of global R&D achievements.

End-to-End Capabilities

Global Strategic Collaborations and Ecosystem

External collaboration has always been a core component of Harbour BioMed's strategic development. We have R&D centers in the United States, Europe, and China, fully leveraging the innovation advantages of each region to serve patients globally.

Technology Service

High quality technology support through fee for service and FTE

Technology License

Access to world's leading fully human Harbour Mice^® platform

Asset License

Novel pipelines with best-in-class potential for global innovation

Co-development

Leverage synergistic advantages to collaboratively develop breakthrough therapies

Strategic Collaboration

Comprehensive long-term collaboration utilizing Harbour's proprietary platform to develop next-generation therapeutics

01/05

For Partnership Enquires: BD@harbourbiomed.com